ICUCW

SeaStar Medical Holding Corporation Warrant

0.0337 USD
+0.0077
29.62%
At close Jul 11, 4:00 PM EDT
1 day
29.62%
5 days
31.13%
1 month
1.20%
3 months
-23.41%
6 months
16.61%
Year to date
40.42%
1 year
-51.16%
5 years
-91.58%
10 years
-91.58%
 

About: SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Employees: 19

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

2.17% less ownership

Funds ownership: 33.9% [Q4 2024] → 31.73% (-2.17%) [Q1 2025]

8% less funds holding

Funds holding: 13 [Q4 2024] → 12 (-1) [Q1 2025]

11% less capital invested

Capital invested by funds: $501K [Q4 2024] → $445K (-$55.4K) [Q1 2025]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Research analyst outlook

We haven’t received any recent analyst ratings for ICUCW.

Financial journalist opinion

We haven’t received any recent news articles for ICUCW.

Charts implemented using Lightweight Charts™